Literature DB >> 11373419

Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis.

J A Hubacek1, F Stüber, D Fröhlich, M Book, S Wetegrove, M Ritter, G Rothe, G Schmitz.   

Abstract

OBJECTIVES: To determine whether the genotype frequencies of the five bi-allelic polymorphisms in the bactericidal/permeability increasing protein (BPI) (Lys216 --> Glu; PstI polymorphism in intron 5; silent mutation G545 --> C) and the lipopolysaccharide binding protein (LBP) (Cys98 --> Gly; Pro436 --> Leu) are associated with the incidence and lethality of sepsis.
DESIGN: Case control study of patients with sepsis.
SETTING: Intensive care units within university hospitals. PATIENTS: A total of 204 patients diagnosed with sepsis and 250 healthy blood donors.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Short DNA fragments containing the polymorphic sites of the LBP and BPI locus were amplified by the polymerase chain reaction or mismatched polymerase chain reaction. The individual polymorphisms were determined with the appropriate restriction enzyme digestions and subsequent agarose gel electrophoresis. The presence of LBP genotypes with the less frequent Gly98 allele was found to be associated with sepsis (p < .02) in male patients, but not in females. Patients which were homozygote for either of the rare Gly98 (n = 6) and/or Leu436 (n = 5) LBP alleles, furthermore, exclusively were nonsurvivors of sepsis. The genotype frequencies in the BPI gene did not differ between patients and control individuals.
CONCLUSIONS: Our findings suggest that common polymorphisms in the gene for LBP in combination with male gender are associated with an increased risk for the development of sepsis and, furthermore, may be linked to an unfavorable outcome. These data support the important immunomodulatory role of LBP in Gram-negative sepsis and suggest that genetic testing may be helpful for the identification of patients with an unfavorable response to Gram-negative infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373419     DOI: 10.1097/00003246-200103000-00015

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  50 in total

Review 1.  The immunopathogenesis of meningococcal disease.

Authors:  A J Kvalsvig; D J Unsworth
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

Review 2.  Assessing the quality of case-control association studies on the genetic basis of sepsis.

Authors:  Sally H Vitali; Adrienne G Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-05       Impact factor: 3.624

Review 3.  Healthcare disparities in critical illness.

Authors:  Graciela J Soto; Greg S Martin; Michelle Ng Gong
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

4.  Association of lipopolysaccharide-binding protein gene polymorphisms with cerebral infarction in a Chinese population.

Authors:  Q Zhan; M Yuan; X H Wang; X M Duan; Q D Yang; J Xia
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

5.  The role of infection and comorbidity: Factors that influence disparities in sepsis.

Authors:  Annette M Esper; Marc Moss; Charmaine A Lewis; Rachel Nisbet; David M Mannino; Greg S Martin
Journal:  Crit Care Med       Date:  2006-10       Impact factor: 7.598

6.  [Complex regional pain syndrome I and II. What effects the outcome?].

Authors:  M Gehling; M Tryba; H Niebergall; A Hufschmidt; M Schild; K Geiger
Journal:  Schmerz       Date:  2003-10       Impact factor: 1.107

7.  Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.

Authors:  Marina Gumenscheimer; Ivan Mitov; Chris Galanos; Marina A Freudenberg
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

8.  Sex- and diagnosis-dependent differences in mortality and admission cytokine levels among patients admitted for intensive care.

Authors:  Christopher A Guidry; Brian R Swenson; Stephen W Davies; Lesly A Dossett; Kimberley A Popovsky; Hugo Bonatti; Heather L Evans; Rosemarie Metzger; Traci L Hedrick; Carlos A Tache-Léon; Tjasa Hranjec; Irshad H Chaudry; Timothy L Pruett; Addison K May; Robert G Sawyer
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

9.  Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis.

Authors:  Jesús Villar; Lina Pérez-Méndez; Elena Espinosa; Carlos Flores; Jesús Blanco; Arturo Muriel; Santiago Basaldúa; Mercedes Muros; Lluis Blanch; Antonio Artigas; Robert M Kacmarek
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

10.  The burden of sepsis-associated mortality in the United States from 1999 to 2005: an analysis of multiple-cause-of-death data.

Authors:  Alexander Melamed; Frank J Sorvillo
Journal:  Crit Care       Date:  2009-02-27       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.